News
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...
2d
Pharmaceutical Technology on MSNValneva’s chikungunya vaccine use halted in older adults amid safety concernsBoth the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...
The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...
In a statement today, the company said it supports recent precautionary measures and that thorough investigations are needed ...
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results